Publicaciones en las que colabora con Armando Torres Ramírez (60)

2022

  1. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study

    BMC Nephrology, Vol. 23, Núm. 1

2021

  1. Hiperoxalurias. Oxalosis

    Nefrología pediátrica (Ediciones de la Universidad de Oviedo), pp. 1011-1020

2019

  1. Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus

    American Journal of Transplantation, Vol. 19, Núm. 12, pp. 3240-3249

2018

  1. Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus

    Kidney International Reports, Vol. 3, Núm. 6, pp. 1304-1315

2017

  1. Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells

    American Journal of Transplantation, Vol. 17, Núm. 11, pp. 2829-2840

  2. Influence of genetic polymorphisms of CYP3A5 and ABCB1 on sirolimus pharmacokinetics, patient and graft survival and other clinical outcomes in renal transplant

    Drug Metabolism and Personalized Therapy, Vol. 32, Núm. 1, pp. 49-58

  3. Molecular therapy of primary hyperoxaluria

    Journal of Inherited Metabolic Disease, Vol. 40, Núm. 4, pp. 481-489

  4. Vascular Damage and Kidney Transplant Outcomes: An Unfriendly and Harmful Link

    American Journal of the Medical Sciences, Vol. 354, Núm. 1, pp. 7-16

2015

  1. Artery wall assessment helps predict kidney transplant outcome

    PLoS ONE, Vol. 10, Núm. 6

  2. Estimated glomerular filtration rate in renal transplantation: The nephrologist in the mist

    Transplantation, Vol. 99, Núm. 12, pp. 2625-2633

  3. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus

    Nefrologia, Vol. 35, Núm. 3, pp. 264-272

2014

  1. Hiperoxaluria primaria

    Nefrologia, Vol. 34, Núm. 3, pp. 398-412

  2. Measurement of glomerular filtration rate: Internal and external validations of the iohexol plasma clearance technique by HPLC

    Clinica Chimica Acta

2013

  1. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean zucker rats

    American Journal of Transplantation, Vol. 13, Núm. 7, pp. 1665-1675

2012

  1. Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation

    Diabetes Care, Vol. 35, Núm. 2, pp. 427-433

2011

  1. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

    Nature Medicine, Vol. 17, Núm. 8, pp. 952-960

  2. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer

    Molecular Therapy, Vol. 19, Núm. 5, pp. 870-875

2010

  1. Tratamiento de inducción combinando inmunoglobulinas, plasmaféresis y rituximab en pacientes hipersensibilizados que reciben trasplante renal de cadáver

    Nefrologia, Vol. 30, Núm. 2, pp. 252-257

2008

  1. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 4, pp. 1436-1441

2007

  1. Carotid atheromatosis in nondiabetic renal transplant recipients: The role of prediabetic glucose homeostasis alterations

    Transplantation, Vol. 84, Núm. 7, pp. 870-875